Vanguard Capital Management’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
Vanguard Capital Management's REPL Position: Q3 2026 in Review
Vanguard Capital Management increased its Replimune Group (REPL) stake by 17% in Q3 2026, buying an estimated $6.32M and bringing the position to 3,395,553 shares worth $45M. The position accounts for ﹤0.01% of the portfolio, ranked #1946.
Vanguard Capital Management first reported a position in REPL in Q1 2026 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold REPL as of Q3 2026.
- Vanguard Capital Management held 3,395,553 shares of Replimune Group worth $45M as of Q3 2026.
- Vanguard Capital Management bought 499,549 Replimune Group shares in Q3 2026, an estimated $6.32M.
- Replimune Group made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1946 holding.
- Vanguard Capital Management first reported a position in Replimune Group in Q1 2026 and has held it in 3 quarters since.
- 208 funds tracked by Wall St. Rank held Replimune Group as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.